星空体育官方入口网站网址大全-登录入口官网

#免疫药物#

12篇内容 | 906人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2162202, encodeId=e60221622023c, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a><a href='/topic/show?id=778528968ee' target=_blank style='color:#2F92EE;'>#免疫制剂#</a>, objectTitle=免疫药物临床药学专家共识, objectType=guider, longId=26474, objectId=bd5461c00338351c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=bd5461c00338351c, replyNumber=0, likeNumber=72, createdTime=2023-10-11, rootId=0, userName=乌云背后的幸福线, userId=d20e5497900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bd5461c00338351c, moduleTitle=免疫药物临床药学专家共识, moduleType=guider, hrefUrl=//m.capotfarm.com/guideline/show_article.do?id=bd5461c00338351c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944064, encodeId=5eaa194406470, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=结直肠癌靶向及免疫药物大盘点，精准治疗时代来了！, objectType=article, longId=728014, objectId=5546e280142e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5546e280142e, replyNumber=0, likeNumber=93, createdTime=2023-05-04, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5546e280142e, moduleTitle=结直肠癌靶向及免疫药物大盘点，精准治疗时代来了！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5546e280142e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944063, encodeId=cd1219440632e, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=不同免疫药物如何合理选择？, objectType=article, longId=294780, objectId=f31b294e8081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f31b294e8081, replyNumber=0, likeNumber=99, createdTime=2022-05-22, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f31b294e8081, moduleTitle=不同免疫药物如何合理选择？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f31b294e8081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944062, encodeId=43bb1944062fa, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=免疫药物联合化疗，晚期鼻咽癌患者可获更长生存期, objectType=article, longId=213487, objectId=2d6121348ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d6121348ebe, replyNumber=0, likeNumber=82, createdTime=2021-08-19, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d6121348ebe, moduleTitle=免疫药物联合化疗，晚期鼻咽癌患者可获更长生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2d6121348ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944060, encodeId=93711944060a1, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=从FDA批准的PD-(L)1类药物适应症看中国肿瘤免疫药物开发进展, objectType=article, longId=161087, objectId=39d816108ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39d816108ef7, replyNumber=0, likeNumber=95, createdTime=2020-01-05, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39d816108ef7, moduleTitle=从FDA批准的PD-(L)1类药物适应症看中国肿瘤免疫药物开发进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=39d816108ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944061, encodeId=f77919440614f, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=诺华15.75亿美元收购IFM Tre，拓展免疫药物管线, objectType=article, longId=163498, objectId=de6716349807, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de6716349807, replyNumber=0, likeNumber=77, createdTime=2019-08-13, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de6716349807, moduleTitle=诺华15.75亿美元收购IFM Tre，拓展免疫药物管线, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=de6716349807)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944059, encodeId=86951944059bb, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=PD-1类肿瘤免疫药物跑步之争：谁占鳌头？, objectType=article, longId=146515, objectId=818e1465155b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=818e1465155b, replyNumber=0, likeNumber=71, createdTime=2019-02-09, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=818e1465155b, moduleTitle=PD-1类肿瘤免疫药物跑步之争：谁占鳌头？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=818e1465155b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944058, encodeId=8676194405866, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=【里程碑】免疫药物引领肺癌治疗划时代标杆, objectType=article, longId=139096, objectId=62521390960e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62521390960e, replyNumber=0, likeNumber=0, createdTime=2019-03-28, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62521390960e, moduleTitle=【里程碑】免疫药物引领肺癌治疗划时代标杆, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=62521390960e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944057, encodeId=b275194405e56, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=J Clin Oncol:免疫药物治疗伴有害DDR突变晚期尿路上皮癌有效率达80%, objectType=article, longId=131677, objectId=aa771316e76f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa771316e76f, replyNumber=0, likeNumber=79, createdTime=2018-12-09, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa771316e76f, moduleTitle=J Clin Oncol:免疫药物治疗伴有害DDR突变晚期尿路上皮癌有效率达80%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aa771316e76f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944056, encodeId=5cc0194405659, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=JAMA Dermat：免疫药物治疗可以使癌症患者的头发变黑？, objectType=article, longId=106350, objectId=241d106350a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=241d106350a7, replyNumber=0, likeNumber=94, createdTime=2017-11-23, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=241d106350a7, moduleTitle=JAMA Dermat：免疫药物治疗可以使癌症患者的头发变黑？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=241d106350a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944055, encodeId=b6f4194405580, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=免疫药物Nivolumab治疗晚期肺癌，5年总生存率为16%, objectType=article, longId=94614, objectId=d6b79461428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6b79461428, replyNumber=0, likeNumber=72, createdTime=2018-02-06, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6b79461428, moduleTitle=免疫药物Nivolumab治疗晚期肺癌，5年总生存率为16%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d6b79461428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944054, encodeId=46a719440548e, content=<a href='/topic/show?id=2af32915564' target=_blank style='color:#2F92EE;'>#免疫药物#</a>, objectTitle=Nature：自体免疫药物反应中的HLA目标, objectType=article, longId=7593, objectId=bd56e5935b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd56e5935b, replyNumber=0, likeNumber=96, createdTime=2013-04-14, rootId=0, userName=yibei, userId=3d1e370, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd56e5935b, moduleTitle=Nature：自体免疫药物反应中的HLA目标, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bd56e5935b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫药物

2020-05-29

乌云背后的幸福线 (审核中...)

前往app查看评论内容

#免疫药物##免疫制剂#

免疫药物临床药学专家共识

2023-10-11发表于上海

yibei (审核中...)

前往app查看评论内容

#免疫药物#

结直肠癌靶向及免疫药物大盘点，精准治疗时代来了！

2023-05-04

yibei (审核中...)

前往app查看评论内容

#免疫药物#

不同免疫药物如何合理选择？

2022-05-22

yibei (审核中...)

前往app查看评论内容

#免疫药物#

免疫药物联合化疗，晚期鼻咽癌患者可获更长生存期

2021-08-19

yibei (审核中...)

前往app查看评论内容

#免疫药物#

从FDA批准的PD-(L)1类药物适应症看中国肿瘤免疫药物开发进展

2020-01-05

yibei (审核中...)

前往app查看评论内容

#免疫药物#

诺华15.75亿美元收购IFM Tre，拓展免疫药物管线

2019-08-13

yibei (审核中...)

前往app查看评论内容

#免疫药物#

PD-1类肿瘤免疫药物跑步之争：谁占鳌头？

2019-02-09

yibei (审核中...)

前往app查看评论内容

#免疫药物#

【里程碑】免疫药物引领肺癌治疗划时代标杆

2019-03-28

yibei (审核中...)

前往app查看评论内容

#免疫药物#

J Clin Oncol:免疫药物治疗伴有害DDR突变晚期尿路上皮癌有效率达80%

2018-12-09

yibei (审核中...)

前往app查看评论内容

#免疫药物#

JAMA Dermat：免疫药物治疗可以使癌症患者的头发变黑？

2017-11-23

yibei (审核中...)

前往app查看评论内容

#免疫药物#

免疫药物Nivolumab治疗晚期肺癌，5年总生存率为16%

2018-02-06

yibei (审核中...)

前往app查看评论内容

#免疫药物#

Nature：自体免疫药物反应中的HLA目标

2013-04-14

科室
- - 订阅+
  - 更多科室
工具
服务